Search

Displaying results 3771 - 3780 of 5040 in total
  1. Drug

    WP-1122

    go.drugbank.com/drugs/DB17192
    Investigational

    WP-1122 is a prodrug of 2-deoxy-D-glucose (2-DG). It was granted FDA orphan designation for the treatment of glioblastoma multiforme.[L47361]

    Synonyms: 3,6-di-O-acetyl-2-deoxy-D-glucopyranose, an acetic acid diester of 2-deoxy-D-glucose
  2. Drug

    WL-1002

    go.drugbank.com/drugs/DB05346
    Experimental

    WL-1002 is developed by Winston Laboratories which is a topical cream formulation of 075% zucapaicin (also known as civamide), for the treatment of pain due to osteoarthritis.

  3. Drug

    Bleselumab

    go.drugbank.com/drugs/DB15253
    Investigational

    Bleselumab is under investigation in clinical trial NCT02921789 (Study to Assess the Efficacy and Safety of Bleselumab in Preventing the Recurrence of Focal Segmental Glomerulosclerosis in de Novo Kidney

  4. Drug

    Plazinemdor

    go.drugbank.com/drugs/DB21493
    Investigational

    Plazinemdor has a monoisotopic molecular weight of 432.12 Da.

  5. Drug

    Derquantel

    go.drugbank.com/drugs/DB19531
    Experimental

    Derquantel has a monoisotopic molecular weight of 479.28 Da.

  6. Drug

    Bepiastine

    go.drugbank.com/drugs/DB19791
    Experimental

    Bepiastine has a monoisotopic molecular weight of 299.11 Da.

  7. Drug

    Clometherone

    go.drugbank.com/drugs/DB19465
    Experimental

    Clometherone has a monoisotopic molecular weight of 362.2 Da.

  8. Drug

    Haloprogesterone

    go.drugbank.com/drugs/DB20259
    Experimental

    Haloprogesterone has a monoisotopic molecular weight of 410.13 Da.

  9. Drug

    Noberastine

    go.drugbank.com/drugs/DB20429
    Experimental

    Noberastine has a monoisotopic molecular weight of 311.17 Da.

  10. Drug

    Pexantel

    go.drugbank.com/drugs/DB20771
    Experimental

    Pexantel has a monoisotopic molecular weight of 210.17 Da.